3) Wallet Drug Company has just recently raised money abroad for the first time in the history of
the firm. Prior to the recent equity issue abroad, the firm had a D/V ratio of 40%, an effective tax
rate of 30%, a before-tax cost of debt of 9%, and a domestic beta of 1.3. The expected return on
the market portfolio was 13% and the risk-free rate was 5%. After the equity issue, Wallet Drug
has a D/V ratio of 50%, their after-tax cost of debt has not changed, nor has the effective tax rate,
the firm’s international beta is 1.0, the expected return on the market portfolio is only 12%, and
the risk-free rate is still 5%. What is the firm’s new cost of equity after the international issue?
A) 9.15%
B) 11.76%
C) 12.00 %
D) 15.40%
4) Wallet Drug Company has just recently raised money abroad for the first time in the history of
the firm. Prior to the recent equity issue abroad, the firm had a D/V ratio of 40%, an effective tax
rate of 30%, a before-tax cost of debt of 9%, and a domestic beta of 1.3. The expected return on
the market portfolio was 13% and the risk-free rate was 5%. After the equity issue, Wallet Drug
has a D/V ratio of 50%, their after-tax cost of debt has not changed, nor has the effective tax rate,
the firm’s international beta is 1.0, the expected return on the market portfolio is only 12%, and
the risk-free rate is still 5%. What is the change in the firm’s WACC after the international equity
issue?
A) 2.61%
B) 1.74%
C) 0.63%
D) There is no change in the firm’s WACC.
5) Which financial economists are most closely associated with the financial theory of optimal
capital structure?
A) Modigliani and Miller
B) Fama, Fisher, Jensen, and Roll
C) Black and Scholes
D) Markowitz and Sharpe